AMBALAL SARABHAI ENTERPRISES
Quarterly Results Analysis [Dec2024]
AMBALAL SARABHAI ENTERPRISES Quarterly Results
Consolidated | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 Audited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹46 Cr | ₹45 Cr | ₹41 Cr | ₹54 Cr | ₹43 Cr | ₹40 Cr | ₹36 Cr | ₹44 Cr |
Expenses | ₹47 Cr | ₹42 Cr | ₹40 Cr | ₹49 Cr | ₹41 Cr | ₹39 Cr | ₹39 Cr | ₹41 Cr |
Operating Income | ₹-1 Cr | ₹3 Cr | ₹1 Cr | ₹6 Cr | ₹3 Cr | ₹1 Cr | ₹-3 Cr | ₹3 Cr |
Other Income | ₹6 Cr | ₹2 Cr | ₹2 Cr | ₹5 Cr | ₹1 Cr | ₹3 Cr | ₹1 Cr | ₹4 Cr |
Interest | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Depreciation | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Profit Before Tax | ₹3 Cr | ₹2 Cr | ₹1 Cr | ₹9 Cr | ₹2 Cr | ₹2 Cr | ₹-4 Cr | ₹6 Cr |
Profit After Tax | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹10 Cr | ₹1 Cr | ₹1 Cr | ₹-4 Cr | ₹4 Cr |
EPS | ₹0.29 | ₹0.34 | ₹0.05 | ₹1.18 | ₹0.15 | ₹0.14 | ₹-0.64 | ₹0.75 |
Industry Peers & Returns | 1W | 1M | 1Y |
AMBALAL SARABHAI ENTERPRISES | -2.5% | -12.3% | -21.6% |
SUN PHARMACEUTICAL INDUSTRIES | -3.4% | -0.2% | 18.1% |
DIVIS LABORATORIES | -2.3% | 3.4% | 55.5% |
CIPLA | -2.6% | -0.6% | 5.9% |
TORRENT PHARMACEUTICALS | -2.3% | -2.1% | 20.4% |
DR REDDYS LABORATORIES | -2.9% | -0.2% | -8.7% |
MANKIND PHARMA | 2.2% | 0.3% | 5% |
ZYDUS LIFESCIENCES | -1.5% | -3.2% | -11.1% |
LUPIN | -2.1% | -3.9% | 25.1% |
AMBALAL SARABHAI ENTERPRISES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 2.83 % |
Y-o-Y | 6.63 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹46 Cr | 2.83 | |
Sep2024 | ₹45 Cr | 9.85 | |
Jun2024 | ₹41 Cr | -25.12 | |
Mar2024 | ₹54 Cr | 26.06 | |
Dec2023 | ₹43 Cr | 7.75 | |
Sep2023 | ₹40 Cr | 10.83 | |
Jun2023 | ₹36 Cr | -18.76 | |
Mar2023 | ₹44 Cr | - |
AMBALAL SARABHAI ENTERPRISES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹-1 Cr | Negative | |
Sep2024 | ₹3 Cr | 203.47 | |
Jun2024 | ₹1 Cr | -85.41 | |
Mar2024 | ₹6 Cr | 126.35 | |
Dec2023 | ₹3 Cr | 140.36 | |
Sep2023 | ₹1 Cr | Positive | |
Jun2023 | ₹-3 Cr | Negative | |
Mar2023 | ₹3 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | -1.53% | Negative | |
Sep2024 | 5.68% | 177.07 | |
Jun2024 | 2.05% | -80.55 | |
Mar2024 | 10.54% | 79.56 | |
Dec2023 | 5.87% | 123.19 | |
Sep2023 | 2.63% | Positive | |
Jun2023 | -8.29% | Negative | |
Mar2023 | 7.53% | - |
AMBALAL SARABHAI ENTERPRISES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 25.65 % |
Y-o-Y | 94.58 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹2 Cr | 25.65 | |
Sep2024 | ₹2 Cr | 133.71 | |
Jun2024 | ₹1 Cr | -92.98 | |
Mar2024 | ₹10 Cr | 843.46 | |
Dec2023 | ₹1 Cr | -4.89 | |
Sep2023 | ₹1 Cr | Positive | |
Jun2023 | ₹-4 Cr | Negative | |
Mar2023 | ₹4 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 22.10 % |
Y-o-Y | 82.66 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 4.53 % | 22.10 | |
Sep2024 | 3.71 % | 113.22 | |
Jun2024 | 1.74 % | -90.64 | |
Mar2024 | 18.58 % | 649.19 | |
Dec2023 | 2.48 % | -11.74 | |
Sep2023 | 2.81 % | Positive | |
Jun2023 | -10.8 % | Negative | |
Mar2023 | 9.81 % | - |
AMBALAL SARABHAI ENTERPRISES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -14.71 % |
Y-o-Y | 93.33 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹0.29 | -14.71 | |
Sep2024 | ₹0.34 | 580.00 | |
Jun2024 | ₹0.05 | -95.76 | |
Mar2024 | ₹1.18 | 686.67 | |
Dec2023 | ₹0.15 | 7.14 | |
Sep2023 | ₹0.14 | Positive | |
Jun2023 | ₹-0.64 | Negative | |
Mar2023 | ₹0.75 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD